Does percutaneous left atrial appendage transcatheter occlusion prevent stroke in high-risk patients with atrial fibrillation?
High-risk patients with atrial fibrillation who are not suitable candidates for anticoagulation therapy
Percutaneous left atrial appendage (LAA) transcatheter occlusion
Feasibility of transcatheter closure of the LAA and stroke prevention
Transcatheter closure of the left atrial appendage is a feasible novel implant technology for patients with atrial fibrillation who are unsuitable for anticoagulation.
Thus, transcatheter closure of the LAA is feasible in humans. This novel implant technology may be appropriate for patients with AF who are not suitable candidates for anticoagulation therapy. Further trials are needed to show the long-term safety and its efficacy in reducing stroke.
Building similarity graph...
Analyzing shared references across papers
Loading...
Horst Sievert
Michael D. Lesh
Thomas Trepels
Circulation
University of California, San Francisco
University Hospital Bonn
Emory University Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Sievert et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69c44441d9a222eddbf4575e — DOI: https://doi.org/10.1161/01.cir.0000015698.54752.6d